BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 19271749)

  • 1. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.
    Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. a potent and selective series for further drug development.
    Lilienkampf A; Pieroni M; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    J Med Chem; 2010 Jan; 53(2):678-88. PubMed ID: 20000577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes.
    Pieroni M; Lilienkampf A; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    J Med Chem; 2009 Oct; 52(20):6287-96. PubMed ID: 19757815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derivatives of 3-isoxazolecarboxylic acid esters: a potent and selective compound class against replicating and nonreplicating Mycobacterium tuberculosis.
    Lilienkampf A; Pieroni M; Franzblau SG; Bishai WR; Kozikowski AP
    Curr Top Med Chem; 2012; 12(7):729-34. PubMed ID: 22283815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification, synthesis, and pharmacological evaluation of tetrahydroindazole based ligands as novel antituberculosis agents.
    Guo S; Song Y; Huang Q; Yuan H; Wan B; Wang Y; He R; Beconi MG; Franzblau SG; Kozikowski AP
    J Med Chem; 2010 Jan; 53(2):649-59. PubMed ID: 20000470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Searching for new cures for tuberculosis: design, synthesis, and biological evaluation of 2-methylbenzothiazoles.
    Huang Q; Mao J; Wan B; Wang Y; Brun R; Franzblau SG; Kozikowski AP
    J Med Chem; 2009 Nov; 52(21):6757-67. PubMed ID: 19817445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
    de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
    Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-hydrogen-8-methylquinolones active against replicating and non-replicating Mycobacterium tuberculosis.
    Tabarrini O; Sabatini S; Massari S; Pieroni M; Franzblau SG; Cecchetti V
    Chem Biol Drug Des; 2012 Nov; 80(5):781-6. PubMed ID: 22889240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in-vitro antimycobacterial evaluation of 1-(cyclopropyl/2,4-difluorophenyl/tert-butyl)-1,4-dihydro- 8-methyl-6-nitro-4-oxo-7-(substituted secondary amino)quinoline-3-carboxylic acids.
    Senthilkumar P; Dinakaran M; Chandraseakaran Y; Yogeeswari P; Sriram D
    Arch Pharm (Weinheim); 2009 Feb; 342(2):100-12. PubMed ID: 19137533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimycobacterial activities of novel 2-(sub)-3-fluoro/nitro-5,12-dihydro-5-oxobenzothiazolo[3,2-a]quinoline-6-carboxylic acid.
    Dinakaran M; Senthilkumar P; Yogeeswari P; China A; Nagaraja V; Sriram D
    Bioorg Med Chem; 2008 Mar; 16(6):3408-18. PubMed ID: 18304818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and pharmacological evaluation of mefloquine-based ligands as novel antituberculosis agents.
    Mao J; Wang Y; Wan B; Kozikowski AP; Franzblau SG
    ChemMedChem; 2007 Nov; 2(11):1624-30. PubMed ID: 17680579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From serendipity to rational antituberculosis drug discovery of mefloquine-isoxazole carboxylic acid esters.
    Mao J; Yuan H; Wang Y; Wan B; Pieroni M; Huang Q; van Breemen RB; Kozikowski AP; Franzblau SG
    J Med Chem; 2009 Nov; 52(22):6966-78. PubMed ID: 19863050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitubercular activities of novel benzothiazolo naphthyridone carboxylic acid derivatives endowed with high activity toward multi-drug resistant tuberculosis.
    Dinakaran M; Senthilkumar P; Yogeeswari P; Sriram D
    Biomed Pharmacother; 2009 Jan; 63(1):11-8. PubMed ID: 18078735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimycobacterial activities of novel 1-(cyclopropyl/tert-butyl/4-fluorophenyl)-1,4-dihydro- 6-nitro-4-oxo-7-(substituted secondary amino)-1,8-naphthyridine-3-carboxylic acid.
    Sriram D; Senthilkumar P; Dinakaran M; Yogeeswari P; China A; Nagaraja V
    J Med Chem; 2007 Nov; 50(24):6232-9. PubMed ID: 17960928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary structure-activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
    Onajole OK; Pieroni M; Tipparaju SK; Lun S; Stec J; Chen G; Gunosewoyo H; Guo H; Ammerman NC; Bishai WR; Kozikowski AP
    J Med Chem; 2013 May; 56(10):4093-103. PubMed ID: 23611124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines.
    Nayyar A; Monga V; Malde A; Coutinho E; Jain R
    Bioorg Med Chem; 2007 Jan; 15(2):626-40. PubMed ID: 17107805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A microwave-assisted, facile, regioselective Friedländer synthesis and antitubercular evaluation of 2,9-diaryl-2,3-dihydrothieno-[3,2-b]quinolines.
    Balamurugan K; Jeyachandran V; Perumal S; Manjashetty TH; Yogeeswari P; Sriram D
    Eur J Med Chem; 2010 Feb; 45(2):682-8. PubMed ID: 19944499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of novel triazole, urea and thiourea derivatives of quinoline against Mycobacterium tuberculosis.
    Upadhayaya RS; Kulkarni GM; Vasireddy NR; Vandavasi JK; Dixit SS; Sharma V; Chattopadhyaya J
    Bioorg Med Chem; 2009 Jul; 17(13):4681-92. PubMed ID: 19457676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.